Kim Geon A, Lee Mi-Jin, Kim Eun Pyo, Heo Gun Ho, Oh Seung Gyu, Park Se Chang, Lee Byeong Chun, Park Sang O
Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Uijeongbu 11759, Republic of Korea.
Department of Veterinary Nursing, College of Health Sciences, Wonkwang University, Iksan 54651, Republic of Korea.
Animals (Basel). 2025 Jun 20;15(13):1825. doi: 10.3390/ani15131825.
BYVET JOINT HEAL (BJH) contains mucopolysaccharide protein, chondroitin sulfate, type II collagen, and omega-3 fatty acids, which protect and prevent osteoarthritis (OA)-associated tissue damage and degradation in dogs and cats. This study aimed to generate a novel dietary supplement and evaluate its prevention and therapeutic efficacy in an OA Sprague Dawley rat model induced using monosodium iodoacetate (MIA). Negative control, MIA-induced OA control (MIA), OA rats treated with BJH three weeks after (M+BJH3) and those treated two weeks before and three weeks after OA induction (BJH2+M+BJH3) groups were assigned. M+BJH3 and BJH2+M+BJH3 had similar mean body weight increases until 29 days. BJH2+M+BJH3 showed a significantly higher body weight than M+BJH3 and MIA on the final day. Interleukin-1β in BJH2+M+BJH3 was significantly lower than that in MIA. Tumor necrosis factor-α, aggrecan, matrix metalloproteinases13, and cyclooxygenase-2 levels in M+BJH3 and BJH2+M+BJH3 significantly differed compared to those in MIA. BJH administration before OA induction significantly decreased OA severity and functional recovery. Consuming a BJH supplement showed modifying and chondroprotective effects and significantly reduced cartilage degeneration and inflammation with no side effects. Hence, our findings demonstrate the potential of using BJH as a safe therapeutic and preventive supplement for OA and associated cartilage abnormalities. Also, 30 dogs diagnosed with OA by a veterinarian participated in the clinical trial, and BJH was provided for 8 weeks. Blood tests (CBC, serum chemistry) and joint assessment were performed before and after the feeding, and the effects of a BJH supplement were compared. BJH supplement was easy to administer, and no side effects were reported. Feeding BJH supplementation alone to dogs with arthritis had an overall positive effect on arthritis scores for 8 weeks without any other treatment, including non-steroidal drugs.
拜维特关节康(BJH)含有黏多糖蛋白、硫酸软骨素、II型胶原蛋白和ω-3脂肪酸,可保护并预防犬猫骨关节炎(OA)相关的组织损伤和退化。本研究旨在研发一种新型膳食补充剂,并在使用碘乙酸钠(MIA)诱导的OA斯普拉格-道利大鼠模型中评估其预防和治疗效果。实验分为阴性对照组、MIA诱导的OA对照组(MIA)、OA诱导三周后用BJH治疗的大鼠组(M+BJH3)以及OA诱导前两周和诱导后三周用BJH治疗的大鼠组(BJH2+M+BJH3)。在29天前,M+BJH3组和BJH2+M+BJH3组的平均体重增加情况相似。在实验最后一天,BJH2+M+BJH3组的体重显著高于M+BJH3组和MIA组。BJH2+M+BJH3组中的白细胞介素-1β显著低于MIA组。与MIA组相比,M+BJH3组和BJH2+M+BJH3组中的肿瘤坏死因子-α、聚集蛋白聚糖、基质金属蛋白酶13和环氧化酶-2水平有显著差异。在OA诱导前给予BJH可显著降低OA严重程度并促进功能恢复。食用BJH补充剂具有改善和软骨保护作用,可显著减少软骨退化和炎症,且无副作用。因此,我们的研究结果表明,BJH作为一种安全的治疗和预防OA及相关软骨异常的补充剂具有潜力。此外,30只经兽医诊断为OA的犬参与了临床试验,BJH连续提供8周。在喂食前后进行血液检测(血常规、血清生化)和关节评估,并比较BJH补充剂的效果。BJH补充剂易于给药,且未报告有副作用。在未经任何其他治疗(包括非甾体类药物)的情况下,单独给患有关节炎的犬喂食BJH补充剂8周,对关节炎评分总体有积极影响。